Cargando…
Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620614/ https://www.ncbi.nlm.nih.gov/pubmed/34829381 http://dx.doi.org/10.3390/diagnostics11112035 |
_version_ | 1784605262609383424 |
---|---|
author | Kuo, Kuang-Che Yang, Ya-Ling Lo, Mao-Hung Cai, Xin-Yuan Guo, Mindy Ming-Huey Kuo, Ho-Chang Huang, Ying-Hsien |
author_facet | Kuo, Kuang-Che Yang, Ya-Ling Lo, Mao-Hung Cai, Xin-Yuan Guo, Mindy Ming-Huey Kuo, Ho-Chang Huang, Ying-Hsien |
author_sort | Kuo, Kuang-Che |
collection | PubMed |
description | Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but this idea has not been discussed much in KD. Materials and Methods: We enrolled 236 participants in this study. In the Affymetrix GeneChip(®) Human Transcriptome Array 2.0 study, there were 18 KD patients analyzed prior to receiving intravenous immunoglobulin (IVIG) treatment, at least 3 weeks after IVIG treatment, and 36 non-KD control subjects. We also recruited 24 KD patients prior to receiving IVIG treatment, at least 3 weeks after IVIG treatment, and 24 non-KD control subjects for Illumina HumanMethylation450 BeadChip study. A separate cohort of 134 subjects was analyzed to validate real-time quantitative PCR. Results: The mRNA levels of caspase-1, -3, -4, and -5 were significantly increased in KD patients compared with control subjects (p < 0.05). After administration of IVIG, the expression of these genes decreased considerably. Of particular note, the methylation status of the CpG sites of the caspase-4 and -5 genes demonstrated significant opposite tendencies between the KD patients and controls. Furthermore, compared with patients who responded to IVIG, refractory KD patients had a lower expression of the caspase-3 gene prior to IVIG treatment. Conclusion: Our study is the first to report the upregulation of pyroptotic caspase-1, -4, and -5 in peripheral leukocytes of KD patients. Moreover, the expression of caspase-3 may be associated with IVIG resistance in KD. |
format | Online Article Text |
id | pubmed-8620614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86206142021-11-27 Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease Kuo, Kuang-Che Yang, Ya-Ling Lo, Mao-Hung Cai, Xin-Yuan Guo, Mindy Ming-Huey Kuo, Ho-Chang Huang, Ying-Hsien Diagnostics (Basel) Article Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but this idea has not been discussed much in KD. Materials and Methods: We enrolled 236 participants in this study. In the Affymetrix GeneChip(®) Human Transcriptome Array 2.0 study, there were 18 KD patients analyzed prior to receiving intravenous immunoglobulin (IVIG) treatment, at least 3 weeks after IVIG treatment, and 36 non-KD control subjects. We also recruited 24 KD patients prior to receiving IVIG treatment, at least 3 weeks after IVIG treatment, and 24 non-KD control subjects for Illumina HumanMethylation450 BeadChip study. A separate cohort of 134 subjects was analyzed to validate real-time quantitative PCR. Results: The mRNA levels of caspase-1, -3, -4, and -5 were significantly increased in KD patients compared with control subjects (p < 0.05). After administration of IVIG, the expression of these genes decreased considerably. Of particular note, the methylation status of the CpG sites of the caspase-4 and -5 genes demonstrated significant opposite tendencies between the KD patients and controls. Furthermore, compared with patients who responded to IVIG, refractory KD patients had a lower expression of the caspase-3 gene prior to IVIG treatment. Conclusion: Our study is the first to report the upregulation of pyroptotic caspase-1, -4, and -5 in peripheral leukocytes of KD patients. Moreover, the expression of caspase-3 may be associated with IVIG resistance in KD. MDPI 2021-11-03 /pmc/articles/PMC8620614/ /pubmed/34829381 http://dx.doi.org/10.3390/diagnostics11112035 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kuo, Kuang-Che Yang, Ya-Ling Lo, Mao-Hung Cai, Xin-Yuan Guo, Mindy Ming-Huey Kuo, Ho-Chang Huang, Ying-Hsien Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title | Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title_full | Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title_fullStr | Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title_full_unstemmed | Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title_short | Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease |
title_sort | increased expression of pyroptosis in leukocytes of patients with kawasaki disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620614/ https://www.ncbi.nlm.nih.gov/pubmed/34829381 http://dx.doi.org/10.3390/diagnostics11112035 |
work_keys_str_mv | AT kuokuangche increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT yangyaling increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT lomaohung increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT caixinyuan increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT guomindyminghuey increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT kuohochang increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease AT huangyinghsien increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease |